I’ll look into it. Great question and I’ve been thinking about it. Especially when I started thinking about MERCK and Keytruda and the patent going off relatively soon. Wouldn’t make sense for them unless they just wanted to replace a PD blocker and join the game again as the enhancer of PDL one.

I think I asked the medical scientist what his thoughts were about the pipeline and PD ones or PDL ones and it didn’t sound like they had much. That’s probably why they are desperate to pair Keytruda with anything trying to get a patent extension.

So to answer your question, I think it’s the company that has the best PD one or PDL one that it’s coming out and has a current one on the market so you can transition easily from the old one to the new one and LL is there the whole time. That’s ideal